Filling the need for trusted information on national health issues…

Trending on kff King v. Burwell Medicaid Expansion Consumer Resources

Kaiser Daily Global Health Policy ReportClinical Research/R&D Search Results « » The Henry J. Kaiser Family Foundation

Clinical Research/R&D

  • your selections
Clear Search

Filter Results

date

Tags

  • results
H1N1 Influenza Deaths Reach 1,000 In India; Different Swine Flu Strain Could Be Responsible For Some, Researcher Says

International Business Times: Swine Flu: Death Toll Reaches 1,000-Mark, 17,000 Diagnosed with H1N1 Virus “Swine flu has claimed 1,000 lives until now with 39 new death cases being reported on Thursday. Meanwhile the reported number of individuals suffering from influenza has crossed the 17,000 mark…” (Das, 2/27). International Business Times:…

‘Science Speaks’ Blog Continues Coverage From CROI 2015

The Center for Global Health Policy’s “Science Speaks” blog continues its coverage of the 2015 Conference on Retroviruses and Opportunistic Infections taking place this week in Seattle, Washington. Science Speaks: Is 90-90-90 nutty? Studies look at numbers behind getting in care, staying in care, suppressing virus, controlling HIV (Barton, 2/26).…

‘Science Speaks’ Blog Continues Coverage From CROI 2015

The Center for Global Health Policy’s “Science Speaks” blog continues its coverage of the 2015 Conference on Retroviruses and Opportunistic Infections taking place this week in Seattle, Washington. Science Speaks: Ambassador Birx talks about the tyranny of averages, actionable data, and “skeptical optimism” (Barton, 2/25). Science Speaks: Amid challenges facing…

USAID-Supported HIV Prevention Trial Produces Disappointing Results, But Leads To Learning, Redoubled Efforts

USAID’s “IMPACTblog”: How Progress Works: A Disappointing Microbicides Trial and Why We’re Not Discouraged David Stanton, director of USAID’s Office of HIV/AIDS, discusses “results released from a large USAID-supported trial [which] indicate that an antiretroviral-based vaginal gel may not be effective in reducing the risk of HIV infection in women…

‘Science Speaks’ Blog Covers Clinical Research Presented At Conference On Retroviruses And Opportunistic Infections

Center for Global Health Policy’s “Science Speaks”: CROI 2015: Study shows “Near elimination of HIV transmission” in a demonstration of PrEP as a bridge to treatment “Science Speaks is covering the 2015 Conference on Retroviruses and Opportunistic Infections in Seattle, Washington, this week, from February 23-26, with breaking news on…

Ebola-Hit Nations Push For Trials Testing Survivor Blood Transfusions As Treatment

Al Jazeera America: Blood transfusions show early promise as possible Ebola cure “…At a meeting held by the World Health Organization on Sept. 5, representatives from Guinea, Sierra Leone, and Liberia pushed for tests on whole blood and blood plasma. ‘The countries really liked the blood option more than the…

Experimental Ebola Drug Shows Promise In Treating Early Infection, Study Shows

Agence France-Presse: Limited promise in early results from Ebola drug trial “Early results from an Ebola trial using the experimental drug Avigan (favipiravir) showed it was somewhat effective at saving lives if given early in the illness, but not later…” (2/23). Reuters: Ebola drug in Guinea helps some, stirs debate…

Quality Of Dietary Habits Declining Worldwide, Study Shows

News outlets report on a study in The Lancet Global Health and a Lancet series on obesity published last week. New York Times: Food Habits Getting Worse Around the World “People in some poor and middle-income countries have healthier diets than those in rich ones, but major Western snack and…